ATF4 and pancreatic neoplasm: Zhang et al. [112] further identified that the small-molecule cyclin-dependent kinase (CDK) inhibitor Hesperadin increases the expression of growth arrest and DNA damage-inducible protein 45α (GADD45A) in pancreatic cancer cells via ATF4 upregulation.